ShiftKey vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
ShiftKey is a technology-driven healthcare staffing marketplace connecting licensed professionals with 10,000+ facilities; unicorn at $2B valuation, raised $300M from Lorient Capital, Ares, Clearlake, and Pantheon.
About
ShiftKey is a healthcare workforce marketplace that connects licensed nurses, certified nursing assistants (CNAs), and other healthcare professionals with hospitals, long-term care facilities, and healthcare systems seeking per-diem staffing. The platform lets clinicians search for available shifts in their area, bid on shifts that match their availability and credentials, and build flexible schedules on their own terms — eliminating the traditional staffing agency middleman and the associated markups. Facilities benefit from a broader, credentialed talent pool with transparent pricing and real-time fill rates.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.